title: Does increasing the opportunity for counseling increase the effectiveness of outpatient drug treatment?
abstract: Increasing the opportunity for group and individual counseling in outpatient drug treatment programs could increase client participation in counseling which, in turn, may enhance program effectiveness. Findings from the evaluation of the Los Angeles Target Cities Enhancement Project indicate that the Target Cities programs successfully increased client participation in group and individual counseling-an increase that cannot be attributed to client characteristics. Further, the magnitude of the increase in group and individual counseling was sufficient to increase the overall effectiveness of Target Cities programs. These findings support the widely held contention among drug treatment providers and policy makers that frequent counseling in necessary for treatment success. They suggest that counselors and other service providers should encourage and facilitate frequent participation in group and individual counseling. Most importantly, the findings indicate that increasing the opportunity for group and individual counseling will increase client participation in counseling, and this increased participation will elevate the overall effectiveness of outpatient drug treatment.
authors.affiliation: UCLA Neuropsychiatric Institute, Drug Abuse Research Center, University of California, Los Angeles 90024, USA. fiore@ucla.edu
authors.forename: R
authors.initials: R
authors.lastname: Fiorentine
authors.forename: M D
authors.initials: MD
authors.lastname: Anglin
mesh_terms: D000293:Adolescent; D000328:Adult; D000553:Ambulatory Care; D005196:Family Therapy; D005260:Female; D005500:Follow-Up Studies; D006297:Health Services Accessibility / Q000706:statistics & numerical data; D006801:Humans; D013287:Illicit Drugs; D015141:Los Angeles / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D010043:Outcome and Process Assessment, Health Care; D010342:Patient Acceptance of Health Care / Q000706:statistics & numerical data; D011613:Psychotherapy; D011615:Psychotherapy, Group; D011619:Psychotropic Drugs; D019966:Substance-Related Disorders / Q000453:epidemiology / Q000534:rehabilitation*
chemical_list: D013287:Illicit Drugs; D011619:Psychotropic Drugs